| Survivors | Non-survivors | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Patient ID | 2 | 3 | 4 | 8 | 10 | 11 | 1* | 5 | 6 | 7 | 9 |
Hospital | 1 | 1 | 2 | 1 | 2 | 2 | 1 | 2 | 2 | 1 | 2 |
Cell type** | UC-MSC | UC-MSC | UC-MSC | PL-MSC | PL-MSC | PL-MSC | UC-MSC | UC-MSC | UC-MSC | PL-MSC | PL-MSC |
Age (years)*** | 60–65 | 55–60 | 65–70 | 60–65 | 40–45 | 45–50 | 65–70 | 50–55 | 55–60 | 35–40 | 60–65 |
Sex (1/2)*** | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 |
Weight (kg) | 80 | 69 | 60 | 95 | 85 | 103 | 80 | 80 | 87 | 85 | 94 |
Underlying disease | HTN, DM | – | CLL | CMP, DM | – | HTN | HTN, DM | – | – | – | DM |
Treatment protocol | HCQ, Kaletra | HCQ, Kaletra | HCQ, Kaletra, Azithromycin, IVIG, Ribavarin | HCQ, Kaletra | Meropenem, Vancomycin, IVIG, Favipiravir | Kaletra, Meropenem, Vancomycin, Tamiflu, IVIG, Favipiravir | HCQ, Kaletra | HCQ, Kaletra, Azithromycin, IVIG, + ECMO | Kaletra, Ribavirin, Vancomycin, Imiper, IVIG | HCQ, Kaletra | Kaletra, Meropenem, Colistin, IVIG |
qRT-PCR | + | + | + | + | + | + | − | + | + | + | + |